Works matching IS 03682811 AND DT 2021 AND VI 51 AND IP 12

Results: 17
    1
    2

    Thanking all peer reviewers.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1697, doi. 10.1093/jjco/hyab186
    Publication type:
    Article
    3

    JJCO Best Reviewer Award.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1702, doi. 10.1093/jjco/hyab179
    Publication type:
    Article
    4
    5
    6

    Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1729, doi. 10.1093/jjco/hyab163
    By:
    • Imano, Nobuki;
    • Kimura, Tomoki;
    • Kawahara, Daisuke;
    • Nishioka, Riku;
    • Fukumoto, Wataru;
    • Kawano, Reo;
    • Kubo, Katsumaro;
    • Katsuta, Tsuyoshi;
    • Takeuchi, Yuki;
    • Nishibuchi, Ikuno;
    • Murakami, Yuji;
    • Horimasu, Yasushi;
    • Masuda, Takeshi;
    • Fujitaka, Kazunori;
    • Hattori, Noboru;
    • Nagata, Yasushi
    Publication type:
    Article
    7

    Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1770, doi. 10.1093/jjco/hyab161
    By:
    • Tomita, Yoshihiko;
    • Kimura, Go;
    • Fukasawa, Satoshi;
    • Numakura, Kazuyuki;
    • Sugiyama, Yutaka;
    • Yamana, Kazutoshi;
    • Naito, Sei;
    • Kaneko, Hirokazu;
    • Tajima, Yohei;
    • Oya, Mototsugu
    Publication type:
    Article
    8

    Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1757, doi. 10.1093/jjco/hyab159
    By:
    • Mizuno, Takaaki;
    • Yoshida, Tatsuya;
    • Sunami, Kuniko;
    • Koyama, Takafumi;
    • Okita, Natsuko;
    • Kubo, Takashi;
    • Sudo, Kazuki;
    • Shimoi, Tatsunori;
    • Ueno, Hideki;
    • Saito, Eiko;
    • Katanoda, Kota;
    • Shibata, Taro;
    • Yonemori, Kan;
    • Okusaka, Takuji;
    • Boku, Narikazu;
    • Ohe, Yuichiro;
    • Hiroshima, Yukihiko;
    • Ueno, Makoto;
    • Kuboki, Yasutoshi;
    • Doi, Toshihiko
    Publication type:
    Article
    9

    Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1736, doi. 10.1093/jjco/hyab158
    By:
    • Wakuda, Kazushige;
    • Yabe, Michitoshi;
    • Kodama, Hiroaki;
    • Nishioka, Naoya;
    • Miyawaki, Taichi;
    • Miyawaki, Eriko;
    • Mamesaya, Nobuaki;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Shimizu, Tetsuo;
    • Gon, Yasuhiro;
    • Takahashi, Toshiaki
    Publication type:
    Article
    10
    11
    12
    13
    14

    Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1751, doi. 10.1093/jjco/hyab142
    By:
    • Ishihara, Hiroki;
    • Kondo, Tsunenori;
    • Nakamura, Kazutaka;
    • Nemoto, Yuki;
    • Tachibana, Hidekazu;
    • Fukuda, Hironori;
    • Yoshida, Kazuhiko;
    • Kobayashi, Hirohito;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Tanabe, Kazunari;
    • Takagi, Toshio
    Publication type:
    Article
    15
    16
    17